Search

everythinglearnresearchcommunity

for

Search:↓

Winter-onset alopecia areata patients are more likely to regrow hair within a year compared to spring-onset patients.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

OCT can detect hidden hair follicles in alopecia areata, indicating potential hair regrowth.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Erdr1 could be a new marker for diagnosing hair loss.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

COVID-19 may trigger alopecia areata, but more research is needed.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

New treatments for severe alopecia areata show promise but lack standard approval.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Minoxidil was more effective than laser therapy for hair loss, and the report also highlighted the need for more research on PRP for a different hair loss condition, the impact of social media on alopecia views, and a warning on turmeric causing nail discoloration.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Unani medicine may help treat a rare, hard-to-treat hair loss pattern in children.

Higher air pollution increases the risk of alopecia areata.

Targeting specific cell interactions may help treat skin fibrosis.